Global Immuno-oncology Diagnosis Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 124

Published Date: 10 Jan 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Immuno-oncology Diagnosis market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Immuno-oncology Diagnosis market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Immuno-oncology Diagnosis market size and forecasts, in consumption value ($ Million), 2018-2029
Global Immuno-oncology Diagnosis market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Immuno-oncology Diagnosis market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Immuno-oncology Diagnosis market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Immuno-oncology Diagnosis
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Immuno-oncology Diagnosis market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include 10x Genomics, Abbott Laboratories, Abcam, Adaptive Biotechnologies and Aethlon Medical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Immuno-oncology Diagnosis market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    PCR
    NGS
    Immunoassay

Market segment by Application
    Research
    Diagnostics

Market segment by players, this report covers
    10x Genomics
    Abbott Laboratories
    Abcam
    Adaptive Biotechnologies
    Aethlon Medical
    Agena Bioscience
    Angle plc
    Apocell
    ARUP Laboratories
    Beckman Coulter
    Becton Dickinson
    Bioarray Genetics
    BioCartis
    Biocept
    Biodesix Inc
    BioFluidica
    BioGenex 40 bioMérieux
    Bio-Rad
    Bio-Techne
    Bristol-Myers Squibb
    Cancer Genetics
    Caris Molecular Diagnostics
    CellMax Life
    Charles River Laboratories
    Chronix Biomedical
    Circulogene
    Clearbridge BioMedics
    Clinical Genomics
    Pfizer
    Promega
    Protagen Diagnostics
    Qiagen
    Quanterix
    Rarecells SAS
    Roche Diagnostics
    Siemens

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Immuno-oncology Diagnosis product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Immuno-oncology Diagnosis, with revenue, gross margin and global market share of Immuno-oncology Diagnosis from 2018 to 2023.
Chapter 3, the Immuno-oncology Diagnosis competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Immuno-oncology Diagnosis market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Immuno-oncology Diagnosis.
Chapter 13, to describe Immuno-oncology Diagnosis research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Immuno-oncology Diagnosis
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Immuno-oncology Diagnosis by Type
        1.3.1 Overview: Global Immuno-oncology Diagnosis Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Immuno-oncology Diagnosis Consumption Value Market Share by Type in 2022
        1.3.3 PCR
        1.3.4 NGS
        1.3.5 Immunoassay
    1.4 Global Immuno-oncology Diagnosis Market by Application
        1.4.1 Overview: Global Immuno-oncology Diagnosis Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Research
        1.4.3 Diagnostics
    1.5 Global Immuno-oncology Diagnosis Market Size & Forecast
    1.6 Global Immuno-oncology Diagnosis Market Size and Forecast by Region
        1.6.1 Global Immuno-oncology Diagnosis Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Immuno-oncology Diagnosis Market Size by Region, (2018-2029)
        1.6.3 North America Immuno-oncology Diagnosis Market Size and Prospect (2018-2029)
        1.6.4 Europe Immuno-oncology Diagnosis Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Immuno-oncology Diagnosis Market Size and Prospect (2018-2029)
        1.6.6 South America Immuno-oncology Diagnosis Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Immuno-oncology Diagnosis Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 10x Genomics
        2.1.1 10x Genomics Details
        2.1.2 10x Genomics Major Business
        2.1.3 10x Genomics Immuno-oncology Diagnosis Product and Solutions
        2.1.4 10x Genomics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 10x Genomics Recent Developments and Future Plans
    2.2 Abbott Laboratories
        2.2.1 Abbott Laboratories Details
        2.2.2 Abbott Laboratories Major Business
        2.2.3 Abbott Laboratories Immuno-oncology Diagnosis Product and Solutions
        2.2.4 Abbott Laboratories Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Abbott Laboratories Recent Developments and Future Plans
    2.3 Abcam
        2.3.1 Abcam Details
        2.3.2 Abcam Major Business
        2.3.3 Abcam Immuno-oncology Diagnosis Product and Solutions
        2.3.4 Abcam Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Abcam Recent Developments and Future Plans
    2.4 Adaptive Biotechnologies
        2.4.1 Adaptive Biotechnologies Details
        2.4.2 Adaptive Biotechnologies Major Business
        2.4.3 Adaptive Biotechnologies Immuno-oncology Diagnosis Product and Solutions
        2.4.4 Adaptive Biotechnologies Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Adaptive Biotechnologies Recent Developments and Future Plans
    2.5 Aethlon Medical
        2.5.1 Aethlon Medical Details
        2.5.2 Aethlon Medical Major Business
        2.5.3 Aethlon Medical Immuno-oncology Diagnosis Product and Solutions
        2.5.4 Aethlon Medical Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Aethlon Medical Recent Developments and Future Plans
    2.6 Agena Bioscience
        2.6.1 Agena Bioscience Details
        2.6.2 Agena Bioscience Major Business
        2.6.3 Agena Bioscience Immuno-oncology Diagnosis Product and Solutions
        2.6.4 Agena Bioscience Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Agena Bioscience Recent Developments and Future Plans
    2.7 Angle plc
        2.7.1 Angle plc Details
        2.7.2 Angle plc Major Business
        2.7.3 Angle plc Immuno-oncology Diagnosis Product and Solutions
        2.7.4 Angle plc Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Angle plc Recent Developments and Future Plans
    2.8 Apocell
        2.8.1 Apocell Details
        2.8.2 Apocell Major Business
        2.8.3 Apocell Immuno-oncology Diagnosis Product and Solutions
        2.8.4 Apocell Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Apocell Recent Developments and Future Plans
    2.9 ARUP Laboratories
        2.9.1 ARUP Laboratories Details
        2.9.2 ARUP Laboratories Major Business
        2.9.3 ARUP Laboratories Immuno-oncology Diagnosis Product and Solutions
        2.9.4 ARUP Laboratories Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 ARUP Laboratories Recent Developments and Future Plans
    2.10 Beckman Coulter
        2.10.1 Beckman Coulter Details
        2.10.2 Beckman Coulter Major Business
        2.10.3 Beckman Coulter Immuno-oncology Diagnosis Product and Solutions
        2.10.4 Beckman Coulter Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Beckman Coulter Recent Developments and Future Plans
    2.11 Becton Dickinson
        2.11.1 Becton Dickinson Details
        2.11.2 Becton Dickinson Major Business
        2.11.3 Becton Dickinson Immuno-oncology Diagnosis Product and Solutions
        2.11.4 Becton Dickinson Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Becton Dickinson Recent Developments and Future Plans
    2.12 Bioarray Genetics
        2.12.1 Bioarray Genetics Details
        2.12.2 Bioarray Genetics Major Business
        2.12.3 Bioarray Genetics Immuno-oncology Diagnosis Product and Solutions
        2.12.4 Bioarray Genetics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Bioarray Genetics Recent Developments and Future Plans
    2.13 BioCartis
        2.13.1 BioCartis Details
        2.13.2 BioCartis Major Business
        2.13.3 BioCartis Immuno-oncology Diagnosis Product and Solutions
        2.13.4 BioCartis Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 BioCartis Recent Developments and Future Plans
    2.14 Biocept
        2.14.1 Biocept Details
        2.14.2 Biocept Major Business
        2.14.3 Biocept Immuno-oncology Diagnosis Product and Solutions
        2.14.4 Biocept Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Biocept Recent Developments and Future Plans
    2.15 Biodesix Inc
        2.15.1 Biodesix Inc Details
        2.15.2 Biodesix Inc Major Business
        2.15.3 Biodesix Inc Immuno-oncology Diagnosis Product and Solutions
        2.15.4 Biodesix Inc Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 Biodesix Inc Recent Developments and Future Plans
    2.16 BioFluidica
        2.16.1 BioFluidica Details
        2.16.2 BioFluidica Major Business
        2.16.3 BioFluidica Immuno-oncology Diagnosis Product and Solutions
        2.16.4 BioFluidica Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        2.16.5 BioFluidica Recent Developments and Future Plans
    2.17 BioGenex 40 bioMérieux
        2.17.1 BioGenex 40 bioMérieux Details
        2.17.2 BioGenex 40 bioMérieux Major Business
        2.17.3 BioGenex 40 bioMérieux Immuno-oncology Diagnosis Product and Solutions
        2.17.4 BioGenex 40 bioMérieux Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        2.17.5 BioGenex 40 bioMérieux Recent Developments and Future Plans
    2.18 Bio-Rad
        2.18.1 Bio-Rad Details
        2.18.2 Bio-Rad Major Business
        2.18.3 Bio-Rad Immuno-oncology Diagnosis Product and Solutions
        2.18.4 Bio-Rad Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        2.18.5 Bio-Rad Recent Developments and Future Plans
    2.19 Bio-Techne
        2.19.1 Bio-Techne Details
        2.19.2 Bio-Techne Major Business
        2.19.3 Bio-Techne Immuno-oncology Diagnosis Product and Solutions
        2.19.4 Bio-Techne Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        2.19.5 Bio-Techne Recent Developments and Future Plans
    2.20 Bristol-Myers Squibb
        2.20.1 Bristol-Myers Squibb Details
        2.20.2 Bristol-Myers Squibb Major Business
        2.20.3 Bristol-Myers Squibb Immuno-oncology Diagnosis Product and Solutions
        2.20.4 Bristol-Myers Squibb Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        2.20.5 Bristol-Myers Squibb Recent Developments and Future Plans
    2.21 Cancer Genetics
        2.21.1 Cancer Genetics Details
        2.21.2 Cancer Genetics Major Business
        2.21.3 Cancer Genetics Immuno-oncology Diagnosis Product and Solutions
        2.21.4 Cancer Genetics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        2.21.5 Cancer Genetics Recent Developments and Future Plans
    2.22 Caris Molecular Diagnostics
        2.22.1 Caris Molecular Diagnostics Details
        2.22.2 Caris Molecular Diagnostics Major Business
        2.22.3 Caris Molecular Diagnostics Immuno-oncology Diagnosis Product and Solutions
        2.22.4 Caris Molecular Diagnostics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        2.22.5 Caris Molecular Diagnostics Recent Developments and Future Plans
    2.23 CellMax Life
        2.23.1 CellMax Life Details
        2.23.2 CellMax Life Major Business
        2.23.3 CellMax Life Immuno-oncology Diagnosis Product and Solutions
        2.23.4 CellMax Life Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        2.23.5 CellMax Life Recent Developments and Future Plans
    2.24 Charles River Laboratories
        2.24.1 Charles River Laboratories Details
        2.24.2 Charles River Laboratories Major Business
        2.24.3 Charles River Laboratories Immuno-oncology Diagnosis Product and Solutions
        2.24.4 Charles River Laboratories Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        2.24.5 Charles River Laboratories Recent Developments and Future Plans
    2.25 Chronix Biomedical
        2.25.1 Chronix Biomedical Details
        2.25.2 Chronix Biomedical Major Business
        2.25.3 Chronix Biomedical Immuno-oncology Diagnosis Product and Solutions
        2.25.4 Chronix Biomedical Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        2.25.5 Chronix Biomedical Recent Developments and Future Plans
    2.26 Circulogene
        2.26.1 Circulogene Details
        2.26.2 Circulogene Major Business
        2.26.3 Circulogene Immuno-oncology Diagnosis Product and Solutions
        2.26.4 Circulogene Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        2.26.5 Circulogene Recent Developments and Future Plans
    2.27 Clearbridge BioMedics
        2.27.1 Clearbridge BioMedics Details
        2.27.2 Clearbridge BioMedics Major Business
        2.27.3 Clearbridge BioMedics Immuno-oncology Diagnosis Product and Solutions
        2.27.4 Clearbridge BioMedics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        2.27.5 Clearbridge BioMedics Recent Developments and Future Plans
    2.28 Clinical Genomics
        2.28.1 Clinical Genomics Details
        2.28.2 Clinical Genomics Major Business
        2.28.3 Clinical Genomics Immuno-oncology Diagnosis Product and Solutions
        2.28.4 Clinical Genomics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        2.28.5 Clinical Genomics Recent Developments and Future Plans
    2.29 Pfizer
        2.29.1 Pfizer Details
        2.29.2 Pfizer Major Business
        2.29.3 Pfizer Immuno-oncology Diagnosis Product and Solutions
        2.29.4 Pfizer Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        2.29.5 Pfizer Recent Developments and Future Plans
    2.30 Promega
        2.30.1 Promega Details
        2.30.2 Promega Major Business
        2.30.3 Promega Immuno-oncology Diagnosis Product and Solutions
        2.30.4 Promega Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        2.30.5 Promega Recent Developments and Future Plans
    2.31 Protagen Diagnostics
        2.31.1 Protagen Diagnostics Details
        2.31.2 Protagen Diagnostics Major Business
        2.31.3 Protagen Diagnostics Immuno-oncology Diagnosis Product and Solutions
        2.31.4 Protagen Diagnostics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        2.31.5 Protagen Diagnostics Recent Developments and Future Plans
    2.32 Qiagen
        2.32.1 Qiagen Details
        2.32.2 Qiagen Major Business
        2.32.3 Qiagen Immuno-oncology Diagnosis Product and Solutions
        2.32.4 Qiagen Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        2.32.5 Qiagen Recent Developments and Future Plans
    2.33 Quanterix
        2.33.1 Quanterix Details
        2.33.2 Quanterix Major Business
        2.33.3 Quanterix Immuno-oncology Diagnosis Product and Solutions
        2.33.4 Quanterix Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        2.33.5 Quanterix Recent Developments and Future Plans
    2.34 Rarecells SAS
        2.34.1 Rarecells SAS Details
        2.34.2 Rarecells SAS Major Business
        2.34.3 Rarecells SAS Immuno-oncology Diagnosis Product and Solutions
        2.34.4 Rarecells SAS Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        2.34.5 Rarecells SAS Recent Developments and Future Plans
    2.35 Roche Diagnostics
        2.35.1 Roche Diagnostics Details
        2.35.2 Roche Diagnostics Major Business
        2.35.3 Roche Diagnostics Immuno-oncology Diagnosis Product and Solutions
        2.35.4 Roche Diagnostics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        2.35.5 Roche Diagnostics Recent Developments and Future Plans
    2.36 Siemens
        2.36.1 Siemens Details
        2.36.2 Siemens Major Business
        2.36.3 Siemens Immuno-oncology Diagnosis Product and Solutions
        2.36.4 Siemens Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
        2.36.5 Siemens Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Immuno-oncology Diagnosis Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Immuno-oncology Diagnosis by Company Revenue
        3.2.2 Top 3 Immuno-oncology Diagnosis Players Market Share in 2022
        3.2.3 Top 6 Immuno-oncology Diagnosis Players Market Share in 2022
    3.3 Immuno-oncology Diagnosis Market: Overall Company Footprint Analysis
        3.3.1 Immuno-oncology Diagnosis Market: Region Footprint
        3.3.2 Immuno-oncology Diagnosis Market: Company Product Type Footprint
        3.3.3 Immuno-oncology Diagnosis Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Immuno-oncology Diagnosis Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Immuno-oncology Diagnosis Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Immuno-oncology Diagnosis Consumption Value Market Share by Application (2018-2023)
    5.2 Global Immuno-oncology Diagnosis Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Immuno-oncology Diagnosis Consumption Value by Type (2018-2029)
    6.2 North America Immuno-oncology Diagnosis Consumption Value by Application (2018-2029)
    6.3 North America Immuno-oncology Diagnosis Market Size by Country
        6.3.1 North America Immuno-oncology Diagnosis Consumption Value by Country (2018-2029)
        6.3.2 United States Immuno-oncology Diagnosis Market Size and Forecast (2018-2029)
        6.3.3 Canada Immuno-oncology Diagnosis Market Size and Forecast (2018-2029)
        6.3.4 Mexico Immuno-oncology Diagnosis Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Immuno-oncology Diagnosis Consumption Value by Type (2018-2029)
    7.2 Europe Immuno-oncology Diagnosis Consumption Value by Application (2018-2029)
    7.3 Europe Immuno-oncology Diagnosis Market Size by Country
        7.3.1 Europe Immuno-oncology Diagnosis Consumption Value by Country (2018-2029)
        7.3.2 Germany Immuno-oncology Diagnosis Market Size and Forecast (2018-2029)
        7.3.3 France Immuno-oncology Diagnosis Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Immuno-oncology Diagnosis Market Size and Forecast (2018-2029)
        7.3.5 Russia Immuno-oncology Diagnosis Market Size and Forecast (2018-2029)
        7.3.6 Italy Immuno-oncology Diagnosis Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Immuno-oncology Diagnosis Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Immuno-oncology Diagnosis Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Immuno-oncology Diagnosis Market Size by Region
        8.3.1 Asia-Pacific Immuno-oncology Diagnosis Consumption Value by Region (2018-2029)
        8.3.2 China Immuno-oncology Diagnosis Market Size and Forecast (2018-2029)
        8.3.3 Japan Immuno-oncology Diagnosis Market Size and Forecast (2018-2029)
        8.3.4 South Korea Immuno-oncology Diagnosis Market Size and Forecast (2018-2029)
        8.3.5 India Immuno-oncology Diagnosis Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Immuno-oncology Diagnosis Market Size and Forecast (2018-2029)
        8.3.7 Australia Immuno-oncology Diagnosis Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Immuno-oncology Diagnosis Consumption Value by Type (2018-2029)
    9.2 South America Immuno-oncology Diagnosis Consumption Value by Application (2018-2029)
    9.3 South America Immuno-oncology Diagnosis Market Size by Country
        9.3.1 South America Immuno-oncology Diagnosis Consumption Value by Country (2018-2029)
        9.3.2 Brazil Immuno-oncology Diagnosis Market Size and Forecast (2018-2029)
        9.3.3 Argentina Immuno-oncology Diagnosis Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Immuno-oncology Diagnosis Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Immuno-oncology Diagnosis Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Immuno-oncology Diagnosis Market Size by Country
        10.3.1 Middle East & Africa Immuno-oncology Diagnosis Consumption Value by Country (2018-2029)
        10.3.2 Turkey Immuno-oncology Diagnosis Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Immuno-oncology Diagnosis Market Size and Forecast (2018-2029)
        10.3.4 UAE Immuno-oncology Diagnosis Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Immuno-oncology Diagnosis Market Drivers
    11.2 Immuno-oncology Diagnosis Market Restraints
    11.3 Immuno-oncology Diagnosis Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Immuno-oncology Diagnosis Industry Chain
    12.2 Immuno-oncology Diagnosis Upstream Analysis
    12.3 Immuno-oncology Diagnosis Midstream Analysis
    12.4 Immuno-oncology Diagnosis Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Immuno-oncology Diagnosis Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Immuno-oncology Diagnosis Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Immuno-oncology Diagnosis Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Immuno-oncology Diagnosis Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. 10x Genomics Company Information, Head Office, and Major Competitors
    Table 6. 10x Genomics Major Business
    Table 7. 10x Genomics Immuno-oncology Diagnosis Product and Solutions
    Table 8. 10x Genomics Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. 10x Genomics Recent Developments and Future Plans
    Table 10. Abbott Laboratories Company Information, Head Office, and Major Competitors
    Table 11. Abbott Laboratories Major Business
    Table 12. Abbott Laboratories Immuno-oncology Diagnosis Product and Solutions
    Table 13. Abbott Laboratories Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Abbott Laboratories Recent Developments and Future Plans
    Table 15. Abcam Company Information, Head Office, and Major Competitors
    Table 16. Abcam Major Business
    Table 17. Abcam Immuno-oncology Diagnosis Product and Solutions
    Table 18. Abcam Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Abcam Recent Developments and Future Plans
    Table 20. Adaptive Biotechnologies Company Information, Head Office, and Major Competitors
    Table 21. Adaptive Biotechnologies Major Business
    Table 22. Adaptive Biotechnologies Immuno-oncology Diagnosis Product and Solutions
    Table 23. Adaptive Biotechnologies Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Adaptive Biotechnologies Recent Developments and Future Plans
    Table 25. Aethlon Medical Company Information, Head Office, and Major Competitors
    Table 26. Aethlon Medical Major Business
    Table 27. Aethlon Medical Immuno-oncology Diagnosis Product and Solutions
    Table 28. Aethlon Medical Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Aethlon Medical Recent Developments and Future Plans
    Table 30. Agena Bioscience Company Information, Head Office, and Major Competitors
    Table 31. Agena Bioscience Major Business
    Table 32. Agena Bioscience Immuno-oncology Diagnosis Product and Solutions
    Table 33. Agena Bioscience Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Agena Bioscience Recent Developments and Future Plans
    Table 35. Angle plc Company Information, Head Office, and Major Competitors
    Table 36. Angle plc Major Business
    Table 37. Angle plc Immuno-oncology Diagnosis Product and Solutions
    Table 38. Angle plc Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Angle plc Recent Developments and Future Plans
    Table 40. Apocell Company Information, Head Office, and Major Competitors
    Table 41. Apocell Major Business
    Table 42. Apocell Immuno-oncology Diagnosis Product and Solutions
    Table 43. Apocell Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Apocell Recent Developments and Future Plans
    Table 45. ARUP Laboratories Company Information, Head Office, and Major Competitors
    Table 46. ARUP Laboratories Major Business
    Table 47. ARUP Laboratories Immuno-oncology Diagnosis Product and Solutions
    Table 48. ARUP Laboratories Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. ARUP Laboratories Recent Developments and Future Plans
    Table 50. Beckman Coulter Company Information, Head Office, and Major Competitors
    Table 51. Beckman Coulter Major Business
    Table 52. Beckman Coulter Immuno-oncology Diagnosis Product and Solutions
    Table 53. Beckman Coulter Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Beckman Coulter Recent Developments and Future Plans
    Table 55. Becton Dickinson Company Information, Head Office, and Major Competitors
    Table 56. Becton Dickinson Major Business
    Table 57. Becton Dickinson Immuno-oncology Diagnosis Product and Solutions
    Table 58. Becton Dickinson Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. Becton Dickinson Recent Developments and Future Plans
    Table 60. Bioarray Genetics Company Information, Head Office, and Major Competitors
    Table 61. Bioarray Genetics Major Business
    Table 62. Bioarray Genetics Immuno-oncology Diagnosis Product and Solutions
    Table 63. Bioarray Genetics Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 64. Bioarray Genetics Recent Developments and Future Plans
    Table 65. BioCartis Company Information, Head Office, and Major Competitors
    Table 66. BioCartis Major Business
    Table 67. BioCartis Immuno-oncology Diagnosis Product and Solutions
    Table 68. BioCartis Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 69. BioCartis Recent Developments and Future Plans
    Table 70. Biocept Company Information, Head Office, and Major Competitors
    Table 71. Biocept Major Business
    Table 72. Biocept Immuno-oncology Diagnosis Product and Solutions
    Table 73. Biocept Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 74. Biocept Recent Developments and Future Plans
    Table 75. Biodesix Inc Company Information, Head Office, and Major Competitors
    Table 76. Biodesix Inc Major Business
    Table 77. Biodesix Inc Immuno-oncology Diagnosis Product and Solutions
    Table 78. Biodesix Inc Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 79. Biodesix Inc Recent Developments and Future Plans
    Table 80. BioFluidica Company Information, Head Office, and Major Competitors
    Table 81. BioFluidica Major Business
    Table 82. BioFluidica Immuno-oncology Diagnosis Product and Solutions
    Table 83. BioFluidica Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 84. BioFluidica Recent Developments and Future Plans
    Table 85. BioGenex 40 bioMérieux Company Information, Head Office, and Major Competitors
    Table 86. BioGenex 40 bioMérieux Major Business
    Table 87. BioGenex 40 bioMérieux Immuno-oncology Diagnosis Product and Solutions
    Table 88. BioGenex 40 bioMérieux Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. BioGenex 40 bioMérieux Recent Developments and Future Plans
    Table 90. Bio-Rad Company Information, Head Office, and Major Competitors
    Table 91. Bio-Rad Major Business
    Table 92. Bio-Rad Immuno-oncology Diagnosis Product and Solutions
    Table 93. Bio-Rad Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 94. Bio-Rad Recent Developments and Future Plans
    Table 95. Bio-Techne Company Information, Head Office, and Major Competitors
    Table 96. Bio-Techne Major Business
    Table 97. Bio-Techne Immuno-oncology Diagnosis Product and Solutions
    Table 98. Bio-Techne Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 99. Bio-Techne Recent Developments and Future Plans
    Table 100. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
    Table 101. Bristol-Myers Squibb Major Business
    Table 102. Bristol-Myers Squibb Immuno-oncology Diagnosis Product and Solutions
    Table 103. Bristol-Myers Squibb Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 104. Bristol-Myers Squibb Recent Developments and Future Plans
    Table 105. Cancer Genetics Company Information, Head Office, and Major Competitors
    Table 106. Cancer Genetics Major Business
    Table 107. Cancer Genetics Immuno-oncology Diagnosis Product and Solutions
    Table 108. Cancer Genetics Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 109. Cancer Genetics Recent Developments and Future Plans
    Table 110. Caris Molecular Diagnostics Company Information, Head Office, and Major Competitors
    Table 111. Caris Molecular Diagnostics Major Business
    Table 112. Caris Molecular Diagnostics Immuno-oncology Diagnosis Product and Solutions
    Table 113. Caris Molecular Diagnostics Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 114. Caris Molecular Diagnostics Recent Developments and Future Plans
    Table 115. CellMax Life Company Information, Head Office, and Major Competitors
    Table 116. CellMax Life Major Business
    Table 117. CellMax Life Immuno-oncology Diagnosis Product and Solutions
    Table 118. CellMax Life Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. CellMax Life Recent Developments and Future Plans
    Table 120. Charles River Laboratories Company Information, Head Office, and Major Competitors
    Table 121. Charles River Laboratories Major Business
    Table 122. Charles River Laboratories Immuno-oncology Diagnosis Product and Solutions
    Table 123. Charles River Laboratories Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 124. Charles River Laboratories Recent Developments and Future Plans
    Table 125. Chronix Biomedical Company Information, Head Office, and Major Competitors
    Table 126. Chronix Biomedical Major Business
    Table 127. Chronix Biomedical Immuno-oncology Diagnosis Product and Solutions
    Table 128. Chronix Biomedical Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 129. Chronix Biomedical Recent Developments and Future Plans
    Table 130. Circulogene Company Information, Head Office, and Major Competitors
    Table 131. Circulogene Major Business
    Table 132. Circulogene Immuno-oncology Diagnosis Product and Solutions
    Table 133. Circulogene Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 134. Circulogene Recent Developments and Future Plans
    Table 135. Clearbridge BioMedics Company Information, Head Office, and Major Competitors
    Table 136. Clearbridge BioMedics Major Business
    Table 137. Clearbridge BioMedics Immuno-oncology Diagnosis Product and Solutions
    Table 138. Clearbridge BioMedics Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 139. Clearbridge BioMedics Recent Developments and Future Plans
    Table 140. Clinical Genomics Company Information, Head Office, and Major Competitors
    Table 141. Clinical Genomics Major Business
    Table 142. Clinical Genomics Immuno-oncology Diagnosis Product and Solutions
    Table 143. Clinical Genomics Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 144. Clinical Genomics Recent Developments and Future Plans
    Table 145. Pfizer Company Information, Head Office, and Major Competitors
    Table 146. Pfizer Major Business
    Table 147. Pfizer Immuno-oncology Diagnosis Product and Solutions
    Table 148. Pfizer Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 149. Pfizer Recent Developments and Future Plans
    Table 150. Promega Company Information, Head Office, and Major Competitors
    Table 151. Promega Major Business
    Table 152. Promega Immuno-oncology Diagnosis Product and Solutions
    Table 153. Promega Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 154. Promega Recent Developments and Future Plans
    Table 155. Protagen Diagnostics Company Information, Head Office, and Major Competitors
    Table 156. Protagen Diagnostics Major Business
    Table 157. Protagen Diagnostics Immuno-oncology Diagnosis Product and Solutions
    Table 158. Protagen Diagnostics Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 159. Protagen Diagnostics Recent Developments and Future Plans
    Table 160. Qiagen Company Information, Head Office, and Major Competitors
    Table 161. Qiagen Major Business
    Table 162. Qiagen Immuno-oncology Diagnosis Product and Solutions
    Table 163. Qiagen Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 164. Qiagen Recent Developments and Future Plans
    Table 165. Quanterix Company Information, Head Office, and Major Competitors
    Table 166. Quanterix Major Business
    Table 167. Quanterix Immuno-oncology Diagnosis Product and Solutions
    Table 168. Quanterix Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 169. Quanterix Recent Developments and Future Plans
    Table 170. Rarecells SAS Company Information, Head Office, and Major Competitors
    Table 171. Rarecells SAS Major Business
    Table 172. Rarecells SAS Immuno-oncology Diagnosis Product and Solutions
    Table 173. Rarecells SAS Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 174. Rarecells SAS Recent Developments and Future Plans
    Table 175. Roche Diagnostics Company Information, Head Office, and Major Competitors
    Table 176. Roche Diagnostics Major Business
    Table 177. Roche Diagnostics Immuno-oncology Diagnosis Product and Solutions
    Table 178. Roche Diagnostics Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 179. Roche Diagnostics Recent Developments and Future Plans
    Table 180. Siemens Company Information, Head Office, and Major Competitors
    Table 181. Siemens Major Business
    Table 182. Siemens Immuno-oncology Diagnosis Product and Solutions
    Table 183. Siemens Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 184. Siemens Recent Developments and Future Plans
    Table 185. Global Immuno-oncology Diagnosis Revenue (USD Million) by Players (2018-2023)
    Table 186. Global Immuno-oncology Diagnosis Revenue Share by Players (2018-2023)
    Table 187. Breakdown of Immuno-oncology Diagnosis by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 188. Market Position of Players in Immuno-oncology Diagnosis, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 189. Head Office of Key Immuno-oncology Diagnosis Players
    Table 190. Immuno-oncology Diagnosis Market: Company Product Type Footprint
    Table 191. Immuno-oncology Diagnosis Market: Company Product Application Footprint
    Table 192. Immuno-oncology Diagnosis New Market Entrants and Barriers to Market Entry
    Table 193. Immuno-oncology Diagnosis Mergers, Acquisition, Agreements, and Collaborations
    Table 194. Global Immuno-oncology Diagnosis Consumption Value (USD Million) by Type (2018-2023)
    Table 195. Global Immuno-oncology Diagnosis Consumption Value Share by Type (2018-2023)
    Table 196. Global Immuno-oncology Diagnosis Consumption Value Forecast by Type (2024-2029)
    Table 197. Global Immuno-oncology Diagnosis Consumption Value by Application (2018-2023)
    Table 198. Global Immuno-oncology Diagnosis Consumption Value Forecast by Application (2024-2029)
    Table 199. North America Immuno-oncology Diagnosis Consumption Value by Type (2018-2023) & (USD Million)
    Table 200. North America Immuno-oncology Diagnosis Consumption Value by Type (2024-2029) & (USD Million)
    Table 201. North America Immuno-oncology Diagnosis Consumption Value by Application (2018-2023) & (USD Million)
    Table 202. North America Immuno-oncology Diagnosis Consumption Value by Application (2024-2029) & (USD Million)
    Table 203. North America Immuno-oncology Diagnosis Consumption Value by Country (2018-2023) & (USD Million)
    Table 204. North America Immuno-oncology Diagnosis Consumption Value by Country (2024-2029) & (USD Million)
    Table 205. Europe Immuno-oncology Diagnosis Consumption Value by Type (2018-2023) & (USD Million)
    Table 206. Europe Immuno-oncology Diagnosis Consumption Value by Type (2024-2029) & (USD Million)
    Table 207. Europe Immuno-oncology Diagnosis Consumption Value by Application (2018-2023) & (USD Million)
    Table 208. Europe Immuno-oncology Diagnosis Consumption Value by Application (2024-2029) & (USD Million)
    Table 209. Europe Immuno-oncology Diagnosis Consumption Value by Country (2018-2023) & (USD Million)
    Table 210. Europe Immuno-oncology Diagnosis Consumption Value by Country (2024-2029) & (USD Million)
    Table 211. Asia-Pacific Immuno-oncology Diagnosis Consumption Value by Type (2018-2023) & (USD Million)
    Table 212. Asia-Pacific Immuno-oncology Diagnosis Consumption Value by Type (2024-2029) & (USD Million)
    Table 213. Asia-Pacific Immuno-oncology Diagnosis Consumption Value by Application (2018-2023) & (USD Million)
    Table 214. Asia-Pacific Immuno-oncology Diagnosis Consumption Value by Application (2024-2029) & (USD Million)
    Table 215. Asia-Pacific Immuno-oncology Diagnosis Consumption Value by Region (2018-2023) & (USD Million)
    Table 216. Asia-Pacific Immuno-oncology Diagnosis Consumption Value by Region (2024-2029) & (USD Million)
    Table 217. South America Immuno-oncology Diagnosis Consumption Value by Type (2018-2023) & (USD Million)
    Table 218. South America Immuno-oncology Diagnosis Consumption Value by Type (2024-2029) & (USD Million)
    Table 219. South America Immuno-oncology Diagnosis Consumption Value by Application (2018-2023) & (USD Million)
    Table 220. South America Immuno-oncology Diagnosis Consumption Value by Application (2024-2029) & (USD Million)
    Table 221. South America Immuno-oncology Diagnosis Consumption Value by Country (2018-2023) & (USD Million)
    Table 222. South America Immuno-oncology Diagnosis Consumption Value by Country (2024-2029) & (USD Million)
    Table 223. Middle East & Africa Immuno-oncology Diagnosis Consumption Value by Type (2018-2023) & (USD Million)
    Table 224. Middle East & Africa Immuno-oncology Diagnosis Consumption Value by Type (2024-2029) & (USD Million)
    Table 225. Middle East & Africa Immuno-oncology Diagnosis Consumption Value by Application (2018-2023) & (USD Million)
    Table 226. Middle East & Africa Immuno-oncology Diagnosis Consumption Value by Application (2024-2029) & (USD Million)
    Table 227. Middle East & Africa Immuno-oncology Diagnosis Consumption Value by Country (2018-2023) & (USD Million)
    Table 228. Middle East & Africa Immuno-oncology Diagnosis Consumption Value by Country (2024-2029) & (USD Million)
    Table 229. Immuno-oncology Diagnosis Raw Material
    Table 230. Key Suppliers of Immuno-oncology Diagnosis Raw Materials
List of Figures
    Figure 1. Immuno-oncology Diagnosis Picture
    Figure 2. Global Immuno-oncology Diagnosis Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Immuno-oncology Diagnosis Consumption Value Market Share by Type in 2022
    Figure 4. PCR
    Figure 5. NGS
    Figure 6. Immunoassay
    Figure 7. Global Immuno-oncology Diagnosis Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 8. Immuno-oncology Diagnosis Consumption Value Market Share by Application in 2022
    Figure 9. Research Picture
    Figure 10. Diagnostics Picture
    Figure 11. Global Immuno-oncology Diagnosis Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 12. Global Immuno-oncology Diagnosis Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 13. Global Market Immuno-oncology Diagnosis Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 14. Global Immuno-oncology Diagnosis Consumption Value Market Share by Region (2018-2029)
    Figure 15. Global Immuno-oncology Diagnosis Consumption Value Market Share by Region in 2022
    Figure 16. North America Immuno-oncology Diagnosis Consumption Value (2018-2029) & (USD Million)
    Figure 17. Europe Immuno-oncology Diagnosis Consumption Value (2018-2029) & (USD Million)
    Figure 18. Asia-Pacific Immuno-oncology Diagnosis Consumption Value (2018-2029) & (USD Million)
    Figure 19. South America Immuno-oncology Diagnosis Consumption Value (2018-2029) & (USD Million)
    Figure 20. Middle East and Africa Immuno-oncology Diagnosis Consumption Value (2018-2029) & (USD Million)
    Figure 21. Global Immuno-oncology Diagnosis Revenue Share by Players in 2022
    Figure 22. Immuno-oncology Diagnosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 23. Global Top 3 Players Immuno-oncology Diagnosis Market Share in 2022
    Figure 24. Global Top 6 Players Immuno-oncology Diagnosis Market Share in 2022
    Figure 25. Global Immuno-oncology Diagnosis Consumption Value Share by Type (2018-2023)
    Figure 26. Global Immuno-oncology Diagnosis Market Share Forecast by Type (2024-2029)
    Figure 27. Global Immuno-oncology Diagnosis Consumption Value Share by Application (2018-2023)
    Figure 28. Global Immuno-oncology Diagnosis Market Share Forecast by Application (2024-2029)
    Figure 29. North America Immuno-oncology Diagnosis Consumption Value Market Share by Type (2018-2029)
    Figure 30. North America Immuno-oncology Diagnosis Consumption Value Market Share by Application (2018-2029)
    Figure 31. North America Immuno-oncology Diagnosis Consumption Value Market Share by Country (2018-2029)
    Figure 32. United States Immuno-oncology Diagnosis Consumption Value (2018-2029) & (USD Million)
    Figure 33. Canada Immuno-oncology Diagnosis Consumption Value (2018-2029) & (USD Million)
    Figure 34. Mexico Immuno-oncology Diagnosis Consumption Value (2018-2029) & (USD Million)
    Figure 35. Europe Immuno-oncology Diagnosis Consumption Value Market Share by Type (2018-2029)
    Figure 36. Europe Immuno-oncology Diagnosis Consumption Value Market Share by Application (2018-2029)
    Figure 37. Europe Immuno-oncology Diagnosis Consumption Value Market Share by Country (2018-2029)
    Figure 38. Germany Immuno-oncology Diagnosis Consumption Value (2018-2029) & (USD Million)
    Figure 39. France Immuno-oncology Diagnosis Consumption Value (2018-2029) & (USD Million)
    Figure 40. United Kingdom Immuno-oncology Diagnosis Consumption Value (2018-2029) & (USD Million)
    Figure 41. Russia Immuno-oncology Diagnosis Consumption Value (2018-2029) & (USD Million)
    Figure 42. Italy Immuno-oncology Diagnosis Consumption Value (2018-2029) & (USD Million)
    Figure 43. Asia-Pacific Immuno-oncology Diagnosis Consumption Value Market Share by Type (2018-2029)
    Figure 44. Asia-Pacific Immuno-oncology Diagnosis Consumption Value Market Share by Application (2018-2029)
    Figure 45. Asia-Pacific Immuno-oncology Diagnosis Consumption Value Market Share by Region (2018-2029)
    Figure 46. China Immuno-oncology Diagnosis Consumption Value (2018-2029) & (USD Million)
    Figure 47. Japan Immuno-oncology Diagnosis Consumption Value (2018-2029) & (USD Million)
    Figure 48. South Korea Immuno-oncology Diagnosis Consumption Value (2018-2029) & (USD Million)
    Figure 49. India Immuno-oncology Diagnosis Consumption Value (2018-2029) & (USD Million)
    Figure 50. Southeast Asia Immuno-oncology Diagnosis Consumption Value (2018-2029) & (USD Million)
    Figure 51. Australia Immuno-oncology Diagnosis Consumption Value (2018-2029) & (USD Million)
    Figure 52. South America Immuno-oncology Diagnosis Consumption Value Market Share by Type (2018-2029)
    Figure 53. South America Immuno-oncology Diagnosis Consumption Value Market Share by Application (2018-2029)
    Figure 54. South America Immuno-oncology Diagnosis Consumption Value Market Share by Country (2018-2029)
    Figure 55. Brazil Immuno-oncology Diagnosis Consumption Value (2018-2029) & (USD Million)
    Figure 56. Argentina Immuno-oncology Diagnosis Consumption Value (2018-2029) & (USD Million)
    Figure 57. Middle East and Africa Immuno-oncology Diagnosis Consumption Value Market Share by Type (2018-2029)
    Figure 58. Middle East and Africa Immuno-oncology Diagnosis Consumption Value Market Share by Application (2018-2029)
    Figure 59. Middle East and Africa Immuno-oncology Diagnosis Consumption Value Market Share by Country (2018-2029)
    Figure 60. Turkey Immuno-oncology Diagnosis Consumption Value (2018-2029) & (USD Million)
    Figure 61. Saudi Arabia Immuno-oncology Diagnosis Consumption Value (2018-2029) & (USD Million)
    Figure 62. UAE Immuno-oncology Diagnosis Consumption Value (2018-2029) & (USD Million)
    Figure 63. Immuno-oncology Diagnosis Market Drivers
    Figure 64. Immuno-oncology Diagnosis Market Restraints
    Figure 65. Immuno-oncology Diagnosis Market Trends
    Figure 66. Porters Five Forces Analysis
    Figure 67. Manufacturing Cost Structure Analysis of Immuno-oncology Diagnosis in 2022
    Figure 68. Manufacturing Process Analysis of Immuno-oncology Diagnosis
    Figure 69. Immuno-oncology Diagnosis Industrial Chain
    Figure 70. Methodology
    Figure 71. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

10x Genomics
Abbott Laboratories
Abcam
Adaptive Biotechnologies
Aethlon Medical
Agena Bioscience
Angle plc
Apocell
ARUP Laboratories
Beckman Coulter
Becton Dickinson
Bioarray Genetics
BioCartis
Biocept
Biodesix Inc
BioFluidica
BioGenex 40 bioMérieux
Bio-Rad
Bio-Techne
Bristol-Myers Squibb
Cancer Genetics
Caris Molecular Diagnostics
CellMax Life
Charles River Laboratories
Chronix Biomedical
Circulogene
Clearbridge BioMedics
Clinical Genomics
Pfizer
Promega
Protagen Diagnostics
Qiagen
Quanterix
Rarecells SAS
Roche Diagnostics
Siemens

Related Reports

Global Immuno-oncology Diagnosis Supply, Demand and Key Producers, 2023-2029

Global Immuno-oncology Diagnosis Supply, Demand and Key Producers, 2023-2029

date 23 Jan 2023

date Medical Care

The global Immuno-oncology Diagnosis market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Immuno-oncology Diagnosis Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Immuno-oncology Diagnosis Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 03 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Immuno-oncology Diagnosis market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Immuno-oncology Diagnosis

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>